Both show strong results in studies, but Retatrutide targets three hormone receptors (GLP-1, GIP, and Glucagon)while Tirzepatide activates two (GLP-1 and GIP)
doi: 10.1038/nrendo.2017.151 3 Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
The diagram emphasizes that adaptive flexibility within this network supports cellular resilience, whereas dysregulationreflected by imbalance among these signaling systemspromotes mitochondrial dysfunction, increased oxidative stress, and heightened susceptibility to pathological states, including addiction and neurodegeneration
If you like the YouTube format, please subscribe
Galindo RJ, Umpierrez GE, Rushakoff RJ et al (2020) Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline
To induce intracellular GSH depletion, cells were incubated in Cys 2 -free medium or with BSO (1000 M) treatment or erastin (10 M) treatment